Wuppertal, Germany

Hilmar Bischoff

USPTO Granted Patents = 100 


Average Co-Inventor Count = 7.6

ph-index = 15

Forward Citations = 1,025(Granted Patents)

Forward Citations (Not Self Cited) = 945(Oct 12, 2025)


Inventors with similar research interests:


Location History:

  • Wuppetal, DE (1998)
  • Wuppertal, DE (1984 - 2012)

Company Filing History:


Years Active: 1984-2012

Loading Chart...
Loading Chart...
100 patents (USPTO):

Title: The Innovative Contributions of Hilmar Bischoff in Cardiovascular Medicine

Introduction

Hilmar Bischoff, a prominent inventor based in Wuppertal, Germany, has significantly impacted the field of cardiovascular medicine through his extensive research and innovative contributions. With an impressive portfolio of 100 patents, Bischoff has focused on developing novel compounds that address various cardiovascular disorders.

Latest Patents

Among his latest inventions are the "Substituted Chromanol Derivatives and Their Use" and "Chemical Compound and Its Use." The first invention centers around substituted chromanol derivatives aimed at treating and preventing diseases, particularly cardiovascular disorders. This invention outlines the preparation processes and the medicinal applications of these compounds. The second patent introduces a novel tetrahydroquinoline derivative, which serves as an inhibitor of the cholesterol ester transfer protein (CETP), targeting conditions such as hypolipoproteinaemias and hypercholesterolaemias. Both patents highlight Bischoff's commitment to advancing cardiovascular therapeutics.

Career Highlights

Bischoff has had a significant career path, during which he worked at Bayer Aktiengesellschaft, a leading global pharmaceutical and life sciences company. His tenure at Bayer has been crucial in shaping his research and development capabilities, enabling him to drive innovations in the pharmaceutical field.

Collaborations

Throughout his career, Hilmar Bischoff has collaborated with notable colleagues, including Delf Schmidt and Rolf Angerbauer. These collaborations have fostered a dynamic environment for sharing ideas and advancing innovative solutions in cardiovascular health.

Conclusion

Hilmar Bischoff's work continues to pave the way for groundbreaking developments in the treatment and prevention of cardiovascular diseases. With a remarkable number of patents and a solid foundation in research and collaboration, he remains a significant figure in the pharmaceutical industry, dedicated to improving global health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…